• Home
  1. Home
  2. A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID ‐19 vaccine with a literature review
Scientific article
Case report
OA Policy
English

A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID ‐19 vaccine with a literature review

ContributorsSheka, Mariaorcid; Coattrenec, Yann; Ing Lorenzini, Kuntheavyorcid; Nendaz, Mathieuorcid
Published inClinical case reports, vol. 11, no. 5, e7184
Publication date2023-05-16
First online date2023-05-16
Abstract

The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID-19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

Keywords
  • 2019‐nCoV vaccine mRNA‐1273
  • COVID‐19
  • COVID‐19 vaccines
  • Drug‐related side effects and adverse reactions
  • Molecular mechanisms of pharmacological action
  • Rhabdomyolysis
Affiliation entities
Research groups
Citation (ISO format)
SHEKA, Maria et al. A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID ‐19 vaccine with a literature review. In: Clinical case reports, 2023, vol. 11, n° 5, p. e7184. doi: 10.1002/ccr3.7184
Main files (1)
Article (Published version)
accessLevelPublic CC BY-NC-ND-4.0
Identifiers
Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/10.1002/ccr3.7184
Journal ISSN2050-0904
152views
227downloads

Technical informations

Creation09/06/2023 07:49:35
First validation04/07/2023 12:31:38
Update09/01/2025 10:23:58
Status update09/01/2025 10:23:58
Last indexation09/01/2025 10:28:26
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack